The combined administration of colchicine and E. rectale to BD mice significantly reduced the frequency of CD83+ cells compared to untreated BD mice (18.67 ± 3.59% vs. 40.72 ± 8.91%, p = 0.01) (Figure 7A). This evidence concerns the gene CD83 and Behcet disease.